Instrument Inactif

Gouvernance Taro Pharmaceutical Industries Ltd.

TARO

IL0010827181

Produits pharmaceutiques

Comité Exécutif: Taro Pharmaceutical Industries Ltd.

Dirigeant

Fonctions occupéesDepuis

William Coote

71 ans

Comptroller/Controller/Auditor	01/12/2021
Director of Finance/CFO	01/12/2021
Investor Relations Contact	01/01/2008

Avi Avramoff

61 ans

Chief Tech/Sci/R&D Officer

01/10/2011

Hagai Reingold

Chief Operating Officer	01/01/2002
Sales & Marketing	01/01/2002

Michele Visosky

60 ans

Human Resources Officer

01/01/2004

Richard Glaze

60 ans

Chief Tech/Sci/R&D Officer

Erik Zwicker

46 ans

General Counsel	13/04/2020
Corporate Secretary	13/04/2020

David Kinzelberg

Comptroller/Controller/Auditor

Composition du Conseil d'Administration: Taro Pharmaceutical Industries Ltd.

Administrateur

ComitésDepuis

Dilip Shantilal Shanghvi

70 ans

Compensation Committee Chair	01/01/1997
Compensation Committee
Nominating Committee

Linda Ben Shoshan

61 ans

Compensation Committee	03/02/2022
Audit Committee Chair	03/01/2017
Audit Committee	03/02/2022
Finance Committee	06/03/2019

Robert Stein

75 ans

Audit Committee	01/02/2020
Compensation Committee	01/02/2020

James Kedrowski

74 ans

Audit Committee	18/05/2011
Compensation Committee	18/05/2011

Oded Sarig

71 ans

Director/Board Member

27/06/2023

Sudhir Vrundavandas Valia

69 ans

Director/Board Member

01/09/2010

Dernières Nominations: Taro Pharmaceutical Industries Ltd.

28/06/23	Taro Pharmaceutical Industries Ltd. nomme M. Oded H. Sarig, Ph. D., au poste d'administrateur	CI
31/05/23	Taro Pharmaceutical Industries Ltd. annonce la démission de Dov Pekelman du conseil d'administration	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Taro Pharmaceutical Industries Ltd.

Insider

Fonctions occupées

DepuisJusqu'au

Uday Vijaykumar Baldota

Director/Board Member	01/12/2016	01/01/2024
Chief Executive Officer	01/08/2017	01/01/2024

Dov Pekelman

Director/Board Member	01/08/2011	30/05/2023
Independent Dir/Board Member	01/08/2011	30/05/2023

Itamar Karsenti

Chief Operating Officer

01/12/2014

01/03/2023

Daphne Yan Huang

Comptroller/Controller/Auditor	06/04/2020	06/08/2021
Director of Finance/CFO	06/04/2020	06/08/2021

Mariano Balaguer

Comptroller/Controller/Auditor	01/10/2016	03/01/2020
Director of Finance/CFO	01/10/2016	03/01/2020

Stephen J. Manzano

Compliance Officer	01/06/2012	01/12/2019
General Counsel	01/06/2012	01/12/2019
Corporate Secretary	01/06/2012	01/12/2019

Ara Aprahamian

Sales & Marketing

01/03/2013

01/08/2018

Kalyanasundaram Subramanian

Director/Board Member	19/04/2012	01/01/2017
Chief Executive Officer	19/04/2012	01/01/2017

Elli Streit

Director/Board Member	01/12/2016	-
Independent Dir/Board Member	01/12/2016	-

Michael Kalb

Comptroller/Controller/Auditor	15/11/2010	29/06/2016
Director of Finance/CFO	22/11/2010	29/06/2016

Jeffrey Holm

Sales & Marketing

01/01/2015

Rami Zajicek

Corporate Officer/Principal

01/04/2006

01/11/2014

Ralph Bohrer

Sales & Marketing

01/09/2013

Aalok Shanghvi

Director/Board Member

27/09/2010

18/07/2013

Sunil Mehta

Corporate Officer/Principal

01/01/2012

Ilan Leviteh

Director/Board Member

23/09/2010

14/11/2011

Sharon Adler

Corporate Officer/Principal

01/11/2011

Hasmukh Shantilal Shah

Director/Board Member

27/09/2010

22/08/2011

Michael Teiler

Corporate Officer/Principal

01/07/2011

Dan Biran

Director/Board Member	30/12/2010	-
Independent Dir/Board Member	30/12/2010	-

Ilana Avidov-Mor

Director/Board Member	30/12/2010	-
Independent Dir/Board Member	30/12/2010	-

Ronald Kolker

Director of Finance/CFO

10/05/2010

15/11/2010

Avraham Yacobi

Chief Tech/Sci/R&D Officer

15/11/2010

Barrie Levitt

Chairman

01/01/1963

22/09/2010

Samuel Rubinstein

Chief Executive Officer

01/01/1990

01/01/2010

Oded Gilboa

Comptroller/Controller/Auditor	01/01/2007	01/01/2009
Director of Finance/CFO	01/01/2007	01/01/2009

Thomas E. McClary

Director of Finance/CFO

30/05/2007

10/04/2008

Orly Amiran

Compliance Officer

01/01/2004

01/01/2007

Ben Zion Hod

Director/Board Member

23/03/2010

Itzik Baruch

Corporate Officer/Principal

17/10/2013

Myron Strober

Director/Board Member

08/01/2010

Micha Friedman

Director/Board Member

08/01/2010

Daniel Moros

Director/Board Member

08/01/2010

Tal Levitt

Director/Board Member	23/03/2010	03/05/2010
Public Communications Contact	23/03/2010	-
Corporate Secretary	01/01/1998	23/03/2010
Treasurer	23/03/2010	-

Heather L. Douglas

Director/Board Member

07/01/2010

Tzvi Tal

Chief Tech/Sci/R&D Officer

01/01/1996

Gad Keren

Director/Board Member

23/03/2010

Mariana Bacalu

Corporate Officer/Principal

01/01/1984

Eric Johnston

Director/Board Member

08/01/2010

Suresh Dixit

Corporate Officer/Principal

Yaron Saporta

Director/Board Member

15/09/2009

Irith Hausner

Director/Board Member

15/09/2009

Peter Giallorenzo

Chief Operating Officer	-	-
Director of Finance/CFO	-	-

Ernest de Paolantonio

Comptroller/Controller/Auditor	-	-
Corporate Officer/Principal	-	-

Peter Geffen

Director/Board Member

Shylah Merrick

Corporate Officer/Principal

Richard Anderson

Corporate Officer/Principal

Alexander Cossin

Corporate Secretary

24/09/2010

Peter Tomlinson

Corporate Officer/Principal

Haim Fainaro

Director/Board Member

23/03/2010

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	14
Femme	2

Dont comité exécutif

Homme	6
Femme	1

Dont Administrateurs

Homme	5
Femme	1

Taro Pharmaceutical Industries Ltd. (Taro) est une société pharmaceutique à vocation scientifique. La société opère principalement par l'intermédiaire de trois entités : Taro Pharmaceutical Industries Ltd. (Taro Israël) et deux de ses filiales, Taro Pharmaceuticals Inc. (Taro Canada) et Taro U.S.A. La société commercialise plus de 200 produits pharmaceutiques dans plus de 25 pays. Les marques détenues par la société comprennent Rokacet, dont les noms génériques sont acétaminophène, codéine et caféine ; Topicort, dont le nom générique est désoximétasone ; Etopan, dont le nom générique est étodolac, et Ovide, dont le nom générique est malathion, parmi d'autres. Les autres produits génériques de la société comprennent l'acétazolamide, l'adapalène, le dipropionate d'alclométasone, le chlorhydrate d'amiodarone, le lactate d'ammonium, le dipropionate de bétaméthasone augmenté, le chlorhydrate de cétirizine, le propionate de clobétasol, le chlorhydrate de clomipramine, le clorazépate dipotassique, le fluorouracil, le kétoconazole, le métronidazole, la mupirocine et la warfarine sodique, entre autres.

Employés

1 554

Secteur

Produits pharmaceutiques

Plus d'informations sur la société